[1]CurrentPatentAssignee:CYCLACELPHARMACEUTICALS,INC.-WO2007/132220,2007,A1Locationinpatent:Page/Pagecolumn43
[1]CurrentPatentAssignee:CYCLACELPHARMACEUTICALS,INC.-WO2004/43953,2004,A1Locationinpatent:Page50
[1]Locationinpatent:experimentalpartWang,Shudong;Midgley,CarolA.;Scaërou,Frederic;Grabarek,JoannaB.;Griffiths,Gary;Jackson,Wayne;Kontopidis,George;McClue,StevenJ.;McInnes,Campbell;Meades,Christopher;Mezna,Mokdad;Plater,Andy;Stuart,Iain;Thomas,MarkP.;Wood,Gavin;Clarke,RosemaryG.;Blake,DavidG.;Zheleva,DaniellaI.;Lane,DavidP.;Jackson,RobertC.;Glover,DavidM.;Fischer,PeterM.[JournalofMedicinalChemistry,2010,vol.53,#11,p.4367-4378]
Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro.
Journal: Archiv der Pharmazie 20111001
Title: An integrated pharmacokinetic-pharmacodynamic model for an Aurora kinase inhibitor.
Journal: Journal of pharmacokinetics and pharmacodynamics 20100801
Title: Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors.
Journal: Journal of medicinal chemistry 20100610
Title: Discovery and development of aurora kinase inhibitors as anticancer agents.
Journal: Journal of medicinal chemistry 20090514
Title: Wang S, et al. Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors. J Med Chem. 2010 Jun 10;53(11):4367-78.
